BSG and Familial prostate cancer: They found CD147 expression to be correlated with all-cause mortality (HR, 2.63; 95% CI, 1.19–5.81) and disease-free survival (HR, 5.84; 95% CI, 3.41–9.99), which shows that CD147 expression has a close association with prostate cancer.